The Journal of Viral Hepatitis publishes reviews, original work (full papers) and short, rapid communications in the area of viral hepatitis. It solicits these articles from epidemiologists, clinicians, pathologists, virologists and specialists in transfusion medicine working in the field, thereby bringing together in a single journal the important issues in this expanding speciality.The Journal of Viral Hepatitis is a monthly journal, publishing reviews, original work (full papers) and short rapid communications in the area of viral hepatitis. It brings together in a single journal important issues in this rapidly expanding speciality including articles from:virologists;epidemiologists;clinicians;pathologists;specialists in transfusion medicine.
《病毒性肝炎杂志》发表病毒性肝炎领域的评论、原创作品（全文）和简短、快速的通讯。它从流行病学家、临床医生、病理学家、病毒学家和输血医学专家那里征集这些文章，从而将这个不断扩大的专业领域的重要问题汇集在一个单一的期刊中。《病毒性肝炎杂志》是一个月刊，发表病毒性肝炎领域的评论、原创工作（全文）和简短的快速通讯。它汇集了在一个单一的杂志在这个迅速扩大的专业重要问题，包括文章从：病毒学家;流行病学家;临床医生;病理学家;输血医学专家。
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13060
Biological basis for functional cure of chronic hepatitis B
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13090
Real‐world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct‐acting antiviral experienced hepatitis C patients
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13115
Roadmap to functional cure of chronic hepatitis B: An expert consensus
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13126
Off‐therapy precipitous HBsAg decline predicts HBsAg loss after finite entecavir therapy in HBeAg‐negative patients
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13114
Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13125
Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13169
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13021
Add‐on peginterferon alfa‐2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen‐negative chronic hepatitis B genotype D
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.12999
Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.12996
Modelling the potential prevention benefits of a treat‐all hepatitis C treatment strategy at global, regional and country levels: A modelling study
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13187
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13104
Management of Hepatitis C Infection in children in the era of Direct‐acting Antiviral Agents
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13113
Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB‐4 for staging liver fibrosis in chronic viral hepatitis
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13246
Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13228
Expression of programmed cell death protein 1 and T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13108
Maternal HBsAg carriers and adverse pregnancy outcomes: A hospital‐based prospective cohort analysis
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13105
COPII cargo claudin‐12 promotes hepatitis C virus entry
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13026
Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13055
Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13193
High rate of hepatitis C reinfection following antiviral treatment in the North East England Prisons
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13240
Real‐world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1‐ and 4‐infected patients with diverse comorbidities and comedications: A pooled analysis of post‐marketing observational studies from 13 countries
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13080
Improving hepatitis C direct‐acting antiviral access and uptake: A role for patient‐reported outcomes and lived experience
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13020
Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13147
Genetic diversity of hepatitis D virus genotype‐1 in Europe allows classification into subtypes
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13086
Advanced liver disease in Russian children and adolescents with chronic hepatitis C
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13093
A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13178
Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13084
HIV co‐infection is associated with increased transmission risk in patients with chronic hepatitis C virus
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13160
Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13208
The dynamic effect of direct‐acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13186
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13050
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13075
Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13232
SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13157
High rates of unprotected anal sex and use of generic direct‐acting antivirals in a cohort of MSM with acute HCV infection
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13066
Attitudes, practices and perceived barriers to hepatitis C screening among medical residents at a large urban academic medical center
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13181
Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13123
Nurse case management to improve the hepatitis C care continuum in HIV co‐infection: Results of a randomized controlled trial
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13241
The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13207
Ovarian HBV replication following ovulation induction in female hepatitis B carriers undergoing IVF treatment: A prospective observational study
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13210
Effectiveness of single‐dose administration of inactivated hepatitis A virus vaccination in the Republic of Korea armed forces, 2013‐2016
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13249
p38 mitogen‐activated protein kinase impairment of innate immune cells is a characteristic feature of HBeAg‐negative chronic hepatitis B
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13209
Trends in chronic hepatitis B prevalence in Australian women by country of birth, 2000 to 2016
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13202
Last crusade against HCV: Direct‐acting antiviral treatment for marginalized populations
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13190
Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13159
Hepatitis B in sub‐Saharan Africa—How many patients need therapy?
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13247
Cytomegalovirus and hepatitis after bone marrow transplantation
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13200
Frequent delayed spontaneous seroclearance of hepatitis B virus after incident HBV infection among adult high‐risk groups
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13205
Unreported alcohol use was common but did not impact hepatitis C cure in HIV‐infected persons who use drugs
来源期刊：Journal of Viral HepatitisDOI：10.1111/jvh.13251
